There is much to read here, but this paragraph near the end is the most interesting to most of us here.
“The paper shows for the first time that both increase and decrease of NF-kB activity , and therefore of immune activity, can determine lifespan,” said Ligoxygakis. “It’s all centered on one molecule.” NF-kB could become a therapeutic target for neurodegenerative diseases, or even prolong health span,” he said, “but the challenge will be to modulate this signaling locally in the brain.”
Seriously? Patrick Cox told us that many years ago!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.